Twist Bioscience Corporation (TWST)
USD 39.82
(2.5%)
USD 39.82
(2.5%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 312.97 Million USD | 27.69% |
| 2023 | 245.1 Million USD | 20.41% |
| 2022 | 203.56 Million USD | 53.83% |
| 2021 | 132.33 Million USD | 46.87% |
| 2020 | 90.1 Million USD | 65.67% |
| 2019 | 54.38 Million USD | 113.89% |
| 2018 | 25.42 Million USD | 136.16% |
| 2017 | 10.76 Million USD | 374.53% |
| 2016 | 2.26 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 71.49 Million USD | 6.8% |
| 2024 Q2 | 75.3 Million USD | 5.32% |
| 2024 Q3 | 81.46 Million USD | 8.18% |
| 2023 FY | 245.1 Million USD | 20.41% |
| 2023 Q4 | 66.94 Million USD | 5.03% |
| 2023 Q2 | 60.18 Million USD | 10.95% |
| 2023 Q1 | 54.24 Million USD | -5.34% |
| 2023 Q3 | 63.74 Million USD | 5.92% |
| 2022 Q3 | 56.11 Million USD | 16.59% |
| 2022 Q4 | 57.3 Million USD | 2.13% |
| 2022 FY | 203.56 Million USD | 53.83% |
| 2022 Q1 | 42.01 Million USD | 10.72% |
| 2022 Q2 | 48.12 Million USD | 14.54% |
| 2021 FY | 132.33 Million USD | 46.87% |
| 2021 Q4 | 37.95 Million USD | 8.38% |
| 2021 Q1 | 28.16 Million USD | -13.17% |
| 2021 Q2 | 31.2 Million USD | 10.81% |
| 2021 Q3 | 35.01 Million USD | 12.22% |
| 2020 Q2 | 19.29 Million USD | 12.43% |
| 2020 FY | 90.1 Million USD | 65.67% |
| 2020 Q1 | 17.16 Million USD | 9.07% |
| 2020 Q4 | 32.43 Million USD | 52.93% |
| 2020 Q3 | 21.2 Million USD | 9.9% |
| 2019 Q4 | 15.73 Million USD | 15.71% |
| 2019 FY | 54.38 Million USD | 113.89% |
| 2019 Q3 | 13.6 Million USD | 0.32% |
| 2019 Q2 | 13.55 Million USD | 17.97% |
| 2019 Q1 | 11.49 Million USD | 36.7% |
| 2018 Q1 | 4.31 Million USD | 24.44% |
| 2018 Q2 | 6.16 Million USD | 42.96% |
| 2018 FY | 25.42 Million USD | 136.16% |
| 2018 Q3 | 6.54 Million USD | 6.08% |
| 2018 Q4 | 8.4 Million USD | 28.53% |
| 2017 FY | 10.76 Million USD | 374.53% |
| 2017 Q3 | 3.17 Million USD | 0.0% |
| 2017 Q4 | 3.46 Million USD | 9.13% |
| 2016 FY | 2.26 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aspira Women's Health Inc. | 9.15 Million USD | -3318.986% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -12258.307% |
| Intelligent Bio Solutions Inc. | 3.11 Million USD | -9957.713% |
| Standard BioTools Inc. | 106.34 Million USD | -194.314% |
| Inotiv, Inc. | 572.42 Million USD | 45.325% |
| Prenetics Global Limited | 21.74 Million USD | -1339.446% |
| Neuronetics, Inc. | 71.34 Million USD | -338.658% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -583.573% |
| Castle Biosciences, Inc. | 219.78 Million USD | -42.398% |
| Psychemedics Corporation | 22.09 Million USD | -1316.3% |
| RadNet, Inc. | 1.61 Billion USD | 80.64% |
| Exact Sciences Corporation | 2.49 Billion USD | 87.48% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | 91.451% |
| iSpecimen Inc. | 9.92 Million USD | -3052.379% |
| OpGen, Inc. | 3.41 Million USD | -9055.784% |
| Exagen Inc. | 52.54 Million USD | -495.596% |
| Bionano Genomics, Inc. | 36.11 Million USD | -766.58% |
| CareDx, Inc | 280.32 Million USD | -11.647% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Guardant Health, Inc. | 563.94 Million USD | 44.503% |
| Biodesix, Inc. | 49.08 Million USD | -537.59% |
| BioNexus Gene Lab Corp. | 9.77 Million USD | -3103.154% |
| Precipio, Inc. | 15.19 Million USD | -1959.446% |
| Natera, Inc. | 1.08 Billion USD | 71.09% |
| Fulgent Genetics, Inc. | 289.21 Million USD | -8.216% |
| Sera Prognostics, Inc. | 306 Thousand USD | -102179.085% |
| 23andMe Holding Co. | 219.63 Million USD | -42.495% |
| OPKO Health, Inc. | 863.49 Million USD | 63.755% |
| Personalis, Inc. | 73.48 Million USD | -325.925% |
| Aclaris Therapeutics, Inc. | 31.24 Million USD | -901.549% |
| Applied DNA Sciences, Inc. | 13.36 Million USD | -2241.315% |
| T2 Biosystems, Inc. | 7.19 Million USD | -4251.091% |
| Neogen Corporation | 924.22 Million USD | 66.136% |
| Myriad Genetics, Inc. | 678.4 Million USD | 53.866% |
| ICON Public Limited Company | 8.12 Billion USD | 96.146% |
| NeoGenomics, Inc. | 591.64 Million USD | 47.101% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -583.573% |
| MDxHealth SA | 70.19 Million USD | -345.876% |
| Prenetics Global Limited | 21.74 Million USD | -1339.446% |
| Illumina, Inc. | 4.5 Billion USD | 93.051% |
| DarioHealth Corp. | 20.35 Million USD | -1437.805% |
| ENDRA Life Sciences Inc. | - USD | -Infinity% |
| Medpace Holdings, Inc. | 1.88 Billion USD | 83.404% |
| Mainz Biomed B.V. | 895.47 Thousand USD | -34850.457% |
| Trinity Biotech plc | 56.83 Million USD | -450.7% |
| Sotera Health Company | 1.04 Billion USD | 70.173% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -12258.307% |